Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271.

MLA

Vellanki, Priyathama, and Guillermo E. Umpierrez. “Response to Comment on Kaminski et Al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271.” Diabetes Care, vol. 47, no. 8, Aug. 2024, pp. e63–64. EBSCOhost, https://doi.org/10.2337/dci24-0031.

APA

Vellanki, P., & Umpierrez, G. E. (2024). Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271. Diabetes Care, 47(8), e63–e64. https://doi.org/10.2337/dci24-0031

Chicago

Vellanki, Priyathama, and Guillermo E Umpierrez. 2024. “Response to Comment on Kaminski et Al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271.” Diabetes Care 47 (8): e63–64. doi:10.2337/dci24-0031.